Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lasagna

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
JAMA|August 10, 1979
The safety and efficacy of the estrogen patient package insert. A questionnaire studyG P Udkow, L Lasagna, M Weintraub, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1972
Experimental bases for the different hepatotoxicity of erythromycin preparations in manC A Dujovne, D Shoeman, J Bianchine, et al.
Clinical Pharmacology and Therapeutics|August 1, 1978
The rate of development of new drugs in the United States, 1963 through 1975W M Wardell, M Hassar, S N Anavekar, et al.
Clinical Pharmacology and Therapeutics|December 1, 1984
Perioperative prophylaxis with cephalosporinsM Madan, G Mehta, M Weintraub, et al.
Bio/Technology (Nature Publishing Company)|May 1, 1992
Biopharmaceuticals and conventional drugs: clinical success ratesB Bienz-Tadmor, P A Dicerbo, G Tadmor, et al.
European Journal of Clinical Pharmacology|March 22, 1976
International co-operation in drug testingT B Binns, F Gross, L Lasagna, et al.
Clinical Pharmacology and Therapeutics|August 1, 1989
The drug lag: an update of new drug introductions in the United States and in the United Kingdom, 1977 through 1987K I Kaitin, N Mattison, F K Northington, et al.
Clinical Pharmacology and Therapeutics|February 1, 1976
Letter: Medical advisers in the pharmaceutical industryT B Binns, F Gross, L Lasagna, et al.
British Journal of Clinical Pharmacology|April 1, 1976
International co-operation in drug testingT B Binns, F Gross, L Lasagna, et al.
Clinical Pharmacology and Therapeutics|April 1, 1979
Methodology for demonstrating sustained efficacy of hypnotics: a comparative study of triazolam and flurazepamP R Sundaresan, W M Wardell, M Weintraub, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
JAMA|August 10, 1979
The safety and efficacy of the estrogen patient package insert. A questionnaire studyG P Udkow, L Lasagna, M Weintraub, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1972
Experimental bases for the different hepatotoxicity of erythromycin preparations in manC A Dujovne, D Shoeman, J Bianchine, et al.
Clinical Pharmacology and Therapeutics|August 1, 1978
The rate of development of new drugs in the United States, 1963 through 1975W M Wardell, M Hassar, S N Anavekar, et al.
Clinical Pharmacology and Therapeutics|December 1, 1984
Perioperative prophylaxis with cephalosporinsM Madan, G Mehta, M Weintraub, et al.
Bio/Technology (Nature Publishing Company)|May 1, 1992
Biopharmaceuticals and conventional drugs: clinical success ratesB Bienz-Tadmor, P A Dicerbo, G Tadmor, et al.
European Journal of Clinical Pharmacology|March 22, 1976
International co-operation in drug testingT B Binns, F Gross, L Lasagna, et al.
Clinical Pharmacology and Therapeutics|August 1, 1989
The drug lag: an update of new drug introductions in the United States and in the United Kingdom, 1977 through 1987K I Kaitin, N Mattison, F K Northington, et al.
Clinical Pharmacology and Therapeutics|February 1, 1976
Letter: Medical advisers in the pharmaceutical industryT B Binns, F Gross, L Lasagna, et al.
British Journal of Clinical Pharmacology|April 1, 1976
International co-operation in drug testingT B Binns, F Gross, L Lasagna, et al.
Clinical Pharmacology and Therapeutics|April 1, 1979
Methodology for demonstrating sustained efficacy of hypnotics: a comparative study of triazolam and flurazepamP R Sundaresan, W M Wardell, M Weintraub, et al.
Pageof 20